BIOMAT Database Logo BIOMAT Database Logo

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation. 1988

G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
Department of Medicine, Tufts-New England Medical Center Hospitals, Boston, Massachusetts 02111.

An ongoing survey of the susceptibility of the Bacteroides fragilis group of bacteria was continued at New England Medical Center in 1984 and 1985. A total of 1,229 strains were obtained from eight centers in the United States. These results were compared with those for 1,847 isolates tested in 1981 through 1983. The most active beta-lactam drugs were imipenem and ticarcillin-clavulanic acid (Timentin), which had a less than 1% resistance rate. No metronidazole- or chloramphenicol-resistant isolates were found during the 5 years of the study. Isolates obtained from blood, perinatal, and bone sites of infection were more resistant to a variety of antimicrobial agents. Susceptibility patterns of the members of the B. fragilis group varied at the eight hospitals and among species. These data indicate the need for determining the susceptibility patterns for the B. fragilis group of organisms at each hospital.

UI MeSH Term Description Entries
D007769 Lactams Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams. Lactam,Lactim,Lactims
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001441 Bacteroides fragilis Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections.
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.

Related Publications

G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.
January 1992, Clinical therapeutics,
G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.
June 1990, The Journal of antimicrobial chemotherapy,
G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
May 2007, Antimicrobial agents and chemotherapy,
G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
Disk diffusion susceptibility testing of the Bacteroides fragilis group.
October 1987, Antimicrobial agents and chemotherapy,
G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
Survey of Bacteroides fragilis group susceptibility patterns in Canada.
February 1992, Antimicrobial agents and chemotherapy,
G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe.
June 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
Antibiotic susceptibility of Bacteroides fragilis group strains in Hungary.
October 1995, Anaerobe,
G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
Survey of Bacteroides fragilis group susceptibility patterns in Brazil.
March 1997, International journal of antimicrobial agents,
G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
Early susceptibility test results with the Bacteroides fragilis group.
December 1993, The Journal of antimicrobial chemotherapy,
G J Cuchural, and F P Tally, and N V Jacobus, and K Aldridge, and T Cleary, and S M Finegold, and G Hill, and P Iannini, and J P O'Keefe, and C Pierson
Haemagglutination by the Bacteroides fragilis group.
March 1986, Journal of medical microbiology,
Copied contents to your clipboard!